Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis Across Nine US Healthcare Systems

DOAC dosing inconsistent with label varied by demographics, clinical characteristics, prescriber specialty, and healthcare system, suggesting a need to monitor and assess dosing decisions in NVAF. Identification of variables associated with dosing inconsistencies may enable targeted interventions to ensure label-consistent dosing in vulnerable populations.

Authors

Institutions

Publication Details

Journal
Journal of General Internal Medicine
Published
2024-10-18
DOI
https://doi.org/10.1007/s11606-024-09106-w
Citations
3
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
1.21

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis Across Nine US Healthcare Systems

Eryne E. Wiethorn, Bonnie DeLor, Carmen Gust, Sara A. Hart et al.
3 citations
Journal of General Internal Medicine
Atrial Fibrillation Management and Outcomes
1.21
article

Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis Across Nine US Healthcare Systems

Eryne E. Wiethorn, Bonnie DeLor, Carmen Gust, Sara A. Hart, Shelby Kelsh, Steven Naylor, Gregory Fakelmann, Laura Duvall, Charles Medico, Richard W. Dettloff, Ukwen Akpoji, Angela Child, Robert D. Bowen, Heather Somand, Chiahung Chou, Timothy J. Hartman, Laura L. Manzey, Jaclynne Gowen, Ann Parks, Mohammad Ateya, Christina Wadsworth, Alexander J Ansara, Trang D Trinh, Jennifer Stanton, Jon Glover, Wesley R. Zemrak, L. Davis, William W. Wilson, Katie Taylor, Saira Naim Haqu, Saba Sarsam
article en
3 citations

Abstract

DOAC dosing inconsistent with label varied by demographics, clinical characteristics, prescriber specialty, and healthcare system, suggesting a need to monitor and assess dosing decisions in NVAF. Identification of variables associated with dosing inconsistencies may enable targeted interventions to ensure label-consistent dosing in vulnerable populations.

Journal of General Internal MedicineVol. 40(4)
Indiana University Health (US), MetroHealth (US), Pfizer (United States) (US), Ferris State University (US), MaineHealth (US), ThedaCare (US), Wentworth Douglass Hospital (US), Parkview Health (US), Baptist Health Louisville (US), Mass General Brigham (US), HealthPartners (US), Indiana University – Purdue University Indianapolis (US)
Bristol-Myers Squibb, Pfizer, Massachusetts General Hospital
Good health and well-being
Openalex Percentile: Top 18%
Atrial Fibrillation Management and Outcomes
1.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.